ABIVAX Société Anonyme (ABVX) News Today $7.35 -0.30 (-3.92%) (As of 05:26 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Abivax Announces a Change to the Composition of its Board of DirectorsDecember 23 at 4:05 PM | globenewswire.comFranklin Resources Inc. Lowers Holdings in ABIVAX Société Anonyme (NASDAQ:ABVX)Franklin Resources Inc. reduced its stake in shares of ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 5.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,324,352 shares of theDecember 21 at 4:46 AM | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Down - Here's What HappenedABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Down - What's Next?December 17, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Up - Still a Buy?ABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Up - Time to Buy?December 16, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Short Interest Up 71.2% in NovemberDecember 14, 2024 | americanbankingnews.comShort Interest in ABIVAX Société Anonyme (NASDAQ:ABVX) Increases By 71.2%ABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) saw a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 484,900 shares, an increase of 71.2% from the November 15th total of 283,200 shares. Based on an average daily trading volume, of 117,700 shares, the short-interest ratio is currently 4.1 days. Currently, 0.9% of the company's stock are sold short.December 12, 2024 | marketbeat.comJanus Henderson Group PLC Cuts Stock Position in ABIVAX Société Anonyme (NASDAQ:ABVX)Janus Henderson Group PLC decreased its holdings in ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 65.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 410,710 shares of the company's stock after selling 764,804 shares during theDecember 11, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Acquired by Point72 Asset Management L.P.Point72 Asset Management L.P. boosted its stake in ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 28.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 542,900 shares of the company's stock after buying anDecember 9, 2024 | marketbeat.comJMP Securities Initiates Coverage of ABIVAX Société Anonyme - Depositary Receipt () (ABVX) with Market Outperform RecommendationDecember 5, 2024 | msn.comABIVAX Société Anonyme (NASDAQ:ABVX) Now Covered by JMP SecuritiesJMP Securities assumed coverage on shares of ABIVAX Société Anonyme in a research note on Wednesday. They issued an "outperform" rating and a $33.00 price target on the stock.December 4, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Acquired by Walleye Capital LLCWalleye Capital LLC lifted its holdings in shares of ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 45.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 257,417 shares of the company's stock afDecember 3, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Down - Time to Sell?ABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Down - Here's What HappenedNovember 29, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Large Increase in Short InterestABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) was the recipient of a large increase in short interest in November. As of November 15th, there was short interest totalling 283,200 shares, an increase of 47.6% from the October 31st total of 191,900 shares. Currently, 0.5% of the company's shares are short sold. Based on an average trading volume of 122,700 shares, the short-interest ratio is currently 2.3 days.November 29, 2024 | marketbeat.comGreat Point Partners LLC Has $24.52 Million Stake in ABIVAX Société Anonyme (NASDAQ:ABVX)Great Point Partners LLC reduced its stake in ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 13.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,128,773 shares of the company's stoNovember 27, 2024 | marketbeat.comAbivax Establishes an At-the-Market (ATM) Program on NasdaqNovember 19, 2024 | globenewswire.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Large Drop in Short InterestABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 191,900 shares, a drop of 15.5% from the October 15th total of 227,200 shares. Based on an average daily volume of 109,700 shares, the days-to-cover ratio is presently 1.7 days. Approximately 0.4% of the shares of the company are short sold.November 16, 2024 | marketbeat.comAbivax appoints industry veteran Mark Stenhouse as advisorNovember 15, 2024 | investing.comAbivax presents third quarter 2024 key financial informationNovember 14, 2024 | globenewswire.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Down - What's Next?ABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Down - Here's What HappenedNovember 14, 2024 | marketbeat.comAbivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to AbivaxNovember 13, 2024 | globenewswire.comRosalind Advisors Inc. Sells 238,433 Shares of ABIVAX Société Anonyme (NASDAQ:ABVX)Rosalind Advisors Inc. reduced its stake in shares of ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 63.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 139,983 shares of the company's stock after selling 238,433 shareNovember 6, 2024 | marketbeat.comabrdn plc Has $3.65 Million Stake in ABIVAX Société Anonyme (NASDAQ:ABVX)abrdn plc raised its holdings in ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 167.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 316,431 shares of the company's stock after buying an additional 198,225 shares durinNovember 4, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Large Volume Increase - Should You Buy?ABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume - Here's What HappenedNovember 1, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Significant Decrease in Short InterestABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 227,200 shares, a decrease of 16.5% from the September 30th total of 272,200 shares. Currently, 0.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 118,000 shares, the days-to-cover ratio is presently 1.9 days.October 28, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume - Here's What HappenedABIVAX Société Anonyme (NASDAQ:ABVX) Sees Strong Trading Volume - Here's What HappenedOctober 24, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume - Should You Buy?ABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume - Still a Buy?October 18, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The averaOctober 17, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Up - Should You Buy?ABIVAX Société Anonyme (NASDAQ:ABVX) Shares Gap Up - Here's What HappenedOctober 11, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Strong Trading Volume - Here's What HappenedABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume - Here's WhyOctober 10, 2024 | marketbeat.comAbivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene RegulationOctober 7, 2024 | globenewswire.comAbivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn's DiseaseOctober 3, 2024 | globenewswire.comAbivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label MaintenanceOctober 3, 2024 | globenewswire.comABIVAX Société Anonyme (NASDAQ:ABVX) Trading Down 4.9%ABIVAX Société Anonyme (NASDAQ:ABVX) Trading Down 4.9%October 2, 2024 | marketbeat.comAbivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024September 26, 2024 | globenewswire.comAbivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse ModelSeptember 25, 2024 | globenewswire.comABIVAX Société Anonyme (NASDAQ:ABVX) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of ABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and six have assSeptember 22, 2024 | marketbeat.comABIVAX Société Anonyme (0RA9.L)September 18, 2024 | nz.finance.yahoo.comABIVAX Société Anonyme (2X10.SG)September 13, 2024 | uk.finance.yahoo.comFY2024 EPS Estimates for ABIVAX Société Anonyme (NASDAQ:ABVX) Raised by Leerink PartnrsABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) - Stock analysts at Leerink Partnrs raised their FY2024 earnings estimates for ABIVAX Société Anonyme in a report released on Monday, September 9th. Leerink Partnrs analyst T. Smith now forecasts that the company will earn ($3.12) per share for tSeptember 12, 2024 | marketbeat.comAbivax presents first-half 2024 financial resultsSeptember 9, 2024 | globenewswire.comABIVAX Société Anonyme (NASDAQ:ABVX) Short Interest Up 72.5% in AugustABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) was the recipient of a significant growth in short interest in August. As of August 15th, there was short interest totalling 166,500 shares, a growth of 72.5% from the July 31st total of 96,500 shares. Approximately 0.3% of the company's stock are short sold. Based on an average daily volume of 62,600 shares, the short-interest ratio is currently 2.7 days.August 29, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Receives Average Rating of "Moderate Buy" from AnalystsShares of ABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and six haveAugust 28, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Stock Price Up 3%ABIVAX Société Anonyme (NASDAQ:ABVX) Trading 3% HigherAugust 27, 2024 | marketbeat.comAbivax SA ADR (ABVX)August 21, 2024 | investing.comABIVAX Société Anonyme (NASDAQ:ABVX) Shares Up 3%ABIVAX Société Anonyme (NASDAQ:ABVX) Trading Up 3%August 20, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Strong Trading VolumeABIVAX Société Anonyme (NASDAQ:ABVX) Sees Strong Trading VolumeAugust 16, 2024 | marketbeat.comABIVAX Société Anonyme (NASDAQ:ABVX) Sees Significant Growth in Short InterestABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) was the target of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 96,500 shares, a growth of 68.7% from the July 15th total of 57,200 shares. Based on an average trading volume of 65,900 shares, the short-interest ratio is presently 1.5 days. Approximately 0.2% of the shares of the company are sold short.August 14, 2024 | marketbeat.comAbivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment MilestoneAugust 6, 2024 | globenewswire.comABIVAX Société Anonyme (NASDAQ:ABVX) Receives Average Recommendation of "Moderate Buy" from BrokeragesABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to thAugust 3, 2024 | marketbeat.comJanus Henderson Group PLC Increases Stock Holdings in ABIVAX Société Anonyme (NASDAQ:ABVX)Janus Henderson Group PLC increased its holdings in shares of ABIVAX Société Anonyme (NASDAQ:ABVX - Free Report) by 18.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 851,839 shares of the company's stock after buyiAugust 2, 2024 | marketbeat.com Get ABIVAX Société Anonyme News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ABVX Media Mentions By Week ABVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABVX News Sentiment▼1.300.59▲Average Medical News Sentiment ABVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABVX Articles This Week▼32▲ABVX Articles Average Week Get ABIVAX Société Anonyme News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMPH News Today IRON News Today TARS News Today CGON News Today HRMY News Today GLPG News Today XNCR News Today EVO News Today ARQT News Today NRIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABVX) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABIVAX Société Anonyme Please log in to your account or sign up in order to add this asset to your watchlist. Share ABIVAX Société Anonyme With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
